Maravai LifeSciences Holdings logo
Maravai LifeSciences Holdings MRVI
$ 7.41 -2.88%

Quarterly report 2024-Q2
added 08-08-2024

report update icon

Maravai LifeSciences Holdings Balance Sheet 2011-2024 | MRVI

Annual Balance Sheet Maravai LifeSciences Holdings

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-49.5 M -104 M -23 M 164 M 313 M 316 M - - - - - - -

Long Term Debt

519 M 522 M 525 M 400 M 335 M 336 M - - - - - - -

Long Term Debt Current

6.78 M 6.27 M 3.72 M - - - - - - - - - -

Total Non Current Liabilities

- - - - 404 M 356 M - - - - - - -

Total Current Liabilities

87.5 M 110 M 93.8 M - - - - - - - - - -

Total Liabilities

698 M 1.38 B 1.37 B 1.12 B 433 M 392 M - - - - - - -

Deferred Revenue

3.36 M 3.09 M 10.2 M 78.1 M 841 K 1.09 M - - - - - - -

Retained Earnings

286 M 405 M 185 M 854 K -42.4 M -38.2 M - - - - - - -

Total Assets

1.49 B 2.28 B 1.92 B 1.27 B 578 M 540 M - - - - - - -

Cash and Cash Equivalents

575 M 632 M 551 M 236 M - - - - - - - - -

Book Value

790 M 905 M 545 M 155 M 145 M 148 M - - - - - - -

Total Shareholders Equity

417 M 545 M 545 M 155 M - - - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet Maravai LifeSciences Holdings

2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

517 M 518 M 520 M 520 M 521 M 522 M - - 524 M 525 M 526 M 527 M 528 M 529 M 529 M 529 M 529 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

671 M 667 M 1.38 B 1.37 B 1.41 B 1.38 B - - 1.39 B 1.37 B 1.44 B 1.27 B 1.14 B 1.12 B 1.12 B 1.12 B 1.12 B - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

2.08 M 2.21 M 2.55 M 2.46 M 2.05 M 3.09 M - - 3.69 M 10.2 M 66.7 M 109 M 119 M 78.1 M 78.1 M 78.1 M 78.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

266 M 274 M 392 M 398 M 405 M 405 M - - 251 M 185 M 127 M 73.2 M 25.6 M 854 K 854 K 854 K 854 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

1.45 B 1.44 B 2.27 B 2.26 B 2.32 B 2.28 B - - 2.04 B 1.92 B 1.89 B 1.6 B 1.35 B 1.27 B 1.27 B 1.27 B 1.27 B - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

573 M 562 M 580 M 580 M 628 M 632 M 617 M 551 M 431 M 551 M 548 M 375 M 248 M 236 M 236 M 236 M 236 M 24.7 M - - - 21.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

776 M 777 M 892 M 898 M 901 M 905 M - - 654 M 545 M 454 M 333 M 210 M 155 M 155 M 155 M 155 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

437 M 411 M 519 M 898 M 901 M 545 M 842 M 774 M 654 M 315 M 303 M 194 M 113 M 88.5 M 88.5 M 88.5 M 88.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency